Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Baxter’s Gammagard meets Phase II study endpoints
The study met the primary endpoint criteria favoring Gammagard Liquid and Gammagard S/D over placebo on measures of cognitive function and global impression of change, which are common
The study met the primary endpoint criteria favoring Gammagard Liquid and Gammagard S/D over placebo on measures of cognitive function and global impression of change, which are common
In preclinical studies, ANA598 was reported to be highly synergistic with interferon-alpha and non-antagonistic with ribavirin in cell-based assays. Furthermore, ANA598 retained full activity against a number of
AlphaVax’s cytomegalovirus (CMV) vaccine was administered three times over six months at one of two dosage levels, and safety and immunogenicity data were obtained from all volunteers following
The study is intended to evaluate the safety, tolerability and efficacy on diabetic type 2 volunteers, using Oramed’s oral insulin capsule. It is anticipated that this study will
Ceapro will apply its patented extraction and processing technologies to create products with cosmeceutical, nutraceutical and pharmaceutical applications. Mark Redmond, Ceapro’s CEO, said: “We expect our growing distributor
The study demonstrated that Copaxone treated patients experienced significantly less brain tissue loss, as measured by percent change in brain volume, compared with patients on other disease-modifying therapies.
The submission is based on the recently completed Phase II/III prospective, double-blind placebo-controlled international multi-center prospective angioedema C1-inhibitor trial, which studied the efficacy of pasteurized C1-INH concentrate. Val
In the preclinical studies, PBI-1737 displayed significant antitumor activity in human prostate cancer both in vitro and in vivo. The in vivo study demonstrated a significant reduction in
The collaboration would involve Neugenesis growing its Neurospora expression system in Sepragen’s solid phase bioreactor system. Neurospora expression systems enable faster production of recombinant proteins than mammalian cells
CryoLife expects to begin distributing Hemostase microporous polysaccharide hemospheres (MPH) in the US in the second quarter of 2008, except to approximately 41 hospitals for which Medafor will